Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice

Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/aps.2016.107, published online 14 November 2016

The authors recently found the original figures of 2.0h and 8.0h after administration of 30 mg/kg afatinib were incorrectly displayed during figure preparation, which resulting in an unintentional misuse. To ensure the integrity and accuracy of the published research, the correct Fig. 4A are now presented.

A IHC revealed modulation of pEGFR in tumor tissue 0.5, 1, 2, 8, and 24 h after administration of 30 mg/kg afatinib.

The authors sincerely apologize for this oversight and any confusion it may have caused to readers and the editorial team. It is important to note that this correction does not alter the findings or conclusions of the paper. The overall interpretation and significance of the research remain unchanged.